New hope for tough childhood cancer cases
Disease control
Recruiting now
This trial is testing whether a targeted antibody drug called naxitamab, given with another medication called GM-CSF, can help control high-risk neuroblastoma in children and adults whose cancer hasn't responded well to previous treatments. About 122 patients with cancer in their…
Phase: PHASE2 • Sponsor: Y-mAbs Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC